Related Experiment Video
Updated: May 20, 2026
07:41
A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
Right ventricular remodeling in pulmonary hypertension.
1Department of Cardiovascular Disease, Pulmonary Hypertension and Adult Congential Heart Disease Program, Advanced Heart Failure and Transplantation Program, The Ohio State University, 473 West 12th Avenue, Columbus, OH 43210, USA. veronica.franco@osumc.edu
Heart Failure Clinics
|July 4, 2012
Summary
Pulmonary arterial hypertension (PAH) causes right ventricle (RV) failure by increasing afterload. New therapies targeting the RV could improve survival for PAH patients.
Area of Science:
- Cardiovascular Medicine
- Pulmonary Hypertension Research
- Right Ventricle Physiology
Background:
- The right ventricle (RV) pumps blood to the lungs for oxygenation.
- Pulmonary arterial hypertension (PAH) increases pulmonary vascular resistance and RV afterload.
- RV afterload increase can lead to RV failure, impacting patient survival.
Purpose of the Study:
- To explore therapeutic strategies directly targeting the right ventricle in PAH.
- To identify potential treatments that support and protect the RV in pulmonary arterial hypertension.
- To enhance long-term survival for patients suffering from PAH.
Main Methods:
- Review of current understanding of RV function in PAH.
- Analysis of existing and potential therapeutic targets for RV support.
- Evaluation of strategies to mitigate RV afterload and remodeling.
Main Results:
- Significant unexploited potential exists for RV-targeted therapies in PAH.
- Directly supporting the RV offers a promising avenue for improving PAH outcomes.
- Therapeutic interventions focusing on RV protection may prolong survival.
Conclusions:
- Targeting the right ventricle is a critical, yet underdeveloped, strategy for managing pulmonary arterial hypertension.
- Developing therapies to support RV function holds promise for improving the prognosis of PAH patients.
- Further research into RV-specific treatments is essential for advancing PAH care and patient survival.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...